Exelixis Inc

EXEL

Sector
Healthcare

Industry
Biotechnology

Website
exelixis.com




Buy / Sell (dollars)

1 Month

8.5% 8.5% Complete (success)
91.5% 91.5% Complete (danger)
$998,520.00
avg. $998,520.00
$10.702M
avg. $10.702M

Buy/Sell Ratio

0.093

Transactions

27

Filers

7

3 Month

12.5% 12.5% Complete (success)
87.5% 87.5% Complete (danger)
$2.916M
avg. $972,131.13
$20.488M
avg. $6.829M

Buy/Sell Ratio

0.142

Transactions

73

Filers

10

12 Month

16.7% 16.7% Complete (success)
83.3% 83.3% Complete (danger)
$8.958M
avg. $746,514.88
$44.687M
avg. $3.724M

Buy/Sell Ratio

0.2

Transactions

171

Filers

17

24 Month

14.2% 14.2% Complete (success)
85.8% 85.8% Complete (danger)
$14.434M
avg. $601,431.49
$87.292M
avg. $3.637M

Buy/Sell Ratio

0.165

Transactions

271

Filers

17

Recent Filings - SEC Form 4


CFO Buys & Sells

The following shows events open market buys and sells made by CFOs. The CFO is likely to be the best person within a company to watch for insider signals.
On the right you can see the maximum upside and downside produced in the 7 months after the filing was made and how long it took to arrive.
These values are updated daily.

CFO data is restricted to data over 5 years old.
You need a free account to see up-to-date data.
Log in to get free access to this feature and more.



Filers